AKTS(Aktis Oncology, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-23 | Czibere Akos | Chief Medical Officer | 公开市场卖出 | 7,401 | $21.03 |
| 2026-09-23 | Czibere Akos | Chief Medical Officer | 公开市场卖出 | 5,099 | $20.19 |
| 2026-07-20 | Herrmann Ken | 董事 | 公开市场卖出 | 1,350 | $24.56 |
| 2026-07-20 | Herrmann Ken | 董事 | 公开市场卖出 | 3,506 | $24.56 |
| 2026-07-17 | Herrmann Ken | 董事 | 公开市场卖出 | 3,065 | $25.21 |
| 2026-07-08 | Ron-Bigger Shulamit | Chief Operating Officer | 公开市场卖出 | 4,200 | $28.75 |
| 2026-07-08 | Ron-Bigger Shulamit | Chief Operating Officer | 公开市场卖出 | 30,000 | $27.94 |
| 2026-07-08 | Ron-Bigger Shulamit | Chief Operating Officer | 公开市场卖出 | 15,800 | $27.13 |
| 2026-07-08 | Czibere Akos | Chief Medical Officer | 公开市场卖出 | 4,371 | $28.71 |
| 2026-07-08 | Czibere Akos | Chief Medical Officer | 公开市场卖出 | 30,829 | $27.95 |
| 2026-07-08 | Czibere Akos | Chief Medical Officer | 公开市场卖出 | 14,800 | $27.13 |
| 2026-01-12 | Foley Todd | 董事、10% 股东 | 公开市场买入 | 232,870 | $18.00 |
| 2026-01-12 | MPM BIOVENTURES 2018, L.P. | 10% 股东 | 公开市场买入 | 1,112,777 | $18.00 |
| 2026-01-12 | GADICKE ANSBERT | 10% 股东 | 公开市场买入 | 1,112,777 | $18.00 |
| 2026-01-12 | Vida Ventures II, LLC | 10% 股东 | 公开市场买入 | 22,545 | $18.00 |
| 2026-01-12 | Vida Ventures II, LLC | 10% 股东 | 公开市场买入 | 812,455 | $18.00 |
| 2026-01-12 | Kim Helen Susan | 董事、10% 股东 | 公开市场买入 | 22,545 | $18.00 |
| 2026-01-12 | Kim Helen Susan | 董事、10% 股东 | 公开市场买入 | 812,455 | $18.00 |
| 2026-01-12 | EcoR1 Capital, LLC | 董事 | 公开市场买入 | 144,443 | $18.00 |
| 2026-01-12 | EcoR1 Capital, LLC | 董事 | 公开市场买入 | 2,077,779 | $18.00 |